GS

Gandla Sushma

Active Director Director DIN 09074207
DIN 09074207 First appointment Feb 2021 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Gandla Sushma

Data last updated:

Gandla Sushma is a Director at Silantro Pharma Private Limited (since 2021). The company operates in Food And Beverages. Silantro Pharma Private Limited reported revenue of ₹31.4 Lakh (FY 2025).

DIN 09074207
Primary Designation Director
Industry Food And Beverages
First Appointment 19 Feb 2021
Oldest Company Age 5 yrs
Largest company Silantro Pharma Private Limited · ₹31.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Silantro Pharma Private Limited U24302TG2021PTC148844
Director19 Feb 20212021₹31.4 Lakh (FY 2025)Active

Board colleagues of Gandla Sushma

Directorship timeline

Open interactive timeline →
Silantro Pharma Private Limited
Premium access

Shareholding and investment profile for Gandla Sushma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gandla Sushma

Gandla Sushma currently holds 1 directorship: Silantro Pharma Private Limited (Director, since 19 Feb 2021, revenue ₹31.4 Lakh (FY 2025)).

Gandla Sushma was first appointed on 19 Feb 2021 as Director at Silantro Pharma Private Limited.

The current boards of Gandla Sushma's companies include Sangeetha Chettupally (Silantro Pharma Private Limited), Suresh Dumala (Silantro Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available